Medicare Enrolled
Dr. Mirela Andrei, M.D.
Hematology · Spokane, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Andrei from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Andrei?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Andrei
Dr. Mirela Andrei is a hematology specialist in Spokane, WA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Andrei performed 49,937 Medicare services across 3,216 unique beneficiaries.
Between the years covered by Open Payments, Dr. Andrei received a total of $17,918 from 92 pharmaceutical and/or device companies across 925 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Andrei is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 8% volume in WA
$17,918 industry payments
Medicare Practice Summary
Medicare Utilization ↗49,937
Medicare services
Top 8% in WA for hematology
3,216
Unique beneficiaries
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,121 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 13,200 | $43 | $157 |
| Denosumab injection (Prolia/Xgeva) | 10,380 | $18 | $64 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
10,318 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 6,110 | $1 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,425 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,264 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,128 | $8 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,116 | $66 | $277 |
| Anti-nausea injection (Aloxi/palonosetron) | 891 | $1 | $41 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
653 | $10 | $39 |
| Anti-nausea injection (ondansetron/Zofran) | 592 | $0 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
344 | $102 | $421 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
291 | $12 | $66 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 200 | $3 | $42 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
184 | $90 | $390 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
180 | $10 | $67 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
165 | $2 | $39 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
110 | $22 | $103 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
106 | $70 | $210 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
99 | $57 | $406 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
91 | $199 | $795 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
88 | $6 | $126 |
| Iron level test | 72 | $6 | $20 |
| New patient office visit, complex (60-74 min) | 57 | $165 | $673 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
56 | $6 | $19 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
56 | $6 | $21 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
53 | $48 | $208 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
52 | $23 | $135 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
51 | $57 | $234 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
50 | $16 | $62 |
| Transferrin level test A blood test that measures the amount of transferrin, a protein that binds to and transports iron in the body. |
48 | $12 | $39 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
47 | $50 | $205 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
47 | $62 | $214 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
46 | $1 | $4 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
40 | $13 | $41 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
38 | $5 | $15 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
33 | $46 | $298 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
33 | $66 | $313 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
32 | $1,266 | $4,774 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
32 | $19 | $70 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
32 | $17 | $83 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 31 | $281 | $1,533 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
27 | $45 | $180 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
25 | $93 | $308 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
22 | $87 | $380 |
| PSA test (prostate cancer screening) | 22 | $18 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
88.6% medium
10.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,918
Total received (2018-2024)
Avg $2,560/year across 7 years
Top 19% in WA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
92
Companies
925
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,619 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$299 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,041
2023
$3,928
2022
$3,462
2021
$3,561
2020
$2,709
2019
$131
2018
$87
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$362
AstraZeneca Pharmaceuticals LP
$339
PFIZER INC.
$323
Incyte Corporation
$254
Genentech USA, Inc.
$246
Novartis Pharmaceuticals Corporation
$227
ABBVIE INC.
$172
Merck Sharp & Dohme LLC
$158
Celgene Corporation
$142
E.R. Squibb & Sons, L.L.C.
$134
Regeneron Healthcare Solutions, Inc.
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$101
Astellas Pharma US Inc
$98
GlaxoSmithKline, LLC.
$89
Takeda Pharmaceuticals U.S.A., Inc.
$86
EMD Serono, Inc.
$82
Eisai Inc.
$82
Acrotech Biopharma Inc.
$79
Blueprint Medicines Corporation
$66
Immunocore Limited
$58
GENZYME CORPORATION
$56
BeiGene USA, Inc.
$50
Alnylam Pharmaceuticals Inc.
$49
Agios Pharmaceuticals, Inc.
$49
JAZZ PHARMACEUTICALS INC.
$45
Tempus AI, Inc
$42
PUMA BIOTECHNOLOGY, INC.
$41
Telix Pharmaceuticals
$41
Bayer Healthcare Pharmaceuticals Inc.
$40
SOBI, INC
$37
TerSera Therapeutics LLC
$33
Deciphera Pharmaceuticals Inc.
$32
Sumitomo Pharma America, Inc.
$30
Dendreon Pharmaceuticals LLC
$30
Daiichi Sankyo Inc.
$29
ARRAY BIOPHARMA INC
$29
SpringWorks Therapeutics, Inc.
$29
Lilly USA, LLC
$24
Exelixis Inc.
$24
ACCORD HEALTHCARE, INC.
$23
PROGENICS PHARMACEUTICALS, INC.
$21
Spectrum Pharmaceuticals Inc.
$21
Mirati Therapeutics, Inc.
$20
Myriad Genetic Laboratories, Inc.
$16
Pharming Healthcare, Inc.
$16
Top 3 companies account for 25.4% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$1,149
PFIZER INC.
$1,023
Amgen Inc.
$995
Genentech USA, Inc.
$921
AstraZeneca Pharmaceuticals LP
$910
E.R. Squibb & Sons, L.L.C.
$897
Celgene Corporation
$852
Novartis Pharmaceuticals Corporation
$712
Incyte Corporation
$592
Takeda Pharmaceuticals U.S.A., Inc.
$488
Astellas Pharma US Inc
$463
Pharmacyclics LLC, An AbbVie Company
$437
Boehringer Ingelheim Pharmaceuticals, Inc.
$424
Eisai Inc.
$388
GENZYME CORPORATION
$383
Merck Sharp & Dohme LLC
$383
Seagen Inc.
$354
GlaxoSmithKline, LLC.
$350
Regeneron Healthcare Solutions, Inc.
$312
Lilly USA, LLC
$291
AbbVie Inc.
$252
EMD Serono, Inc.
$230
Blueprint Medicines Corporation
$230
Myriad Genetic Laboratories, Inc.
$228
BeiGene USA, Inc.
$227
JAZZ PHARMACEUTICALS INC.
$226
ABBVIE INC.
$195
Bayer HealthCare Pharmaceuticals Inc.
$148
Alnylam Pharmaceuticals Inc.
$146
TerSera Therapeutics LLC
$145
Agios Pharmaceuticals, Inc.
$137
Exelixis Inc.
$131
Acrotech Biopharma LLC
$125
Deciphera Pharmaceuticals Inc.
$122
Immunomedics, Inc.
$119
Taiho Oncology, Inc.
$117
EISAI INC.
$113
MorphoSys, US Inc.
$111
PUMA BIOTECHNOLOGY, INC.
$106
ARRAY BIOPHARMA INC
$104
Acrotech Biopharma Inc.
$100
Ipsen Biopharmaceuticals, Inc
$97
Kite Pharma, Inc.
$94
Daiichi Sankyo Inc.
$92
Immunocore Limited
$91
Myovant Sciences Inc.
$90
Bayer Healthcare Pharmaceuticals Inc.
$88
Pharmacyclics LLC, an AbbVie Company
$87
Foundation Medicine, Inc.
$78
EUSA Pharma (US) LLC
$69
Acceleron Pharma, Inc.
$65
SOBI, INC
$63
Dendreon Pharmaceuticals LLC
$59
Gilead Sciences, Inc.
$58
AVEO Pharmaceuticals, Inc.
$55
AMAG Pharmaceuticals, Inc.
$55
Stemline Therapeutics Inc.
$55
Pharmacosmos Therapeutics Inc.
$55
Karyopharm Therapeutics Inc.
$53
CTI BioPharma Corp.
$53
Sumitomo Pharma America, Inc.
$52
Kyowa Kirin, Inc.
$51
Aurobindo Pharma USA, Inc.
$50
Adaptive Biotechnologies Corporation
$44
SERVIER PHARMACEUTICALS LLC
$43
Rigel Pharmaceuticals, Inc.
$43
Merck Sharp & Dohme Corporation
$42
Tempus AI, Inc
$42
Telix Pharmaceuticals
$41
Dova Pharmaceuticals
$40
SANOFI-AVENTIS U.S. LLC
$40
Secura Bio, Inc.
$33
Stryker Corporation
$31
Sirtex Medical Inc
$29
SpringWorks Therapeutics, Inc.
$29
Sun Pharmaceutical Industries Inc.
$24
Puma Biotechnology, Inc.
$23
ACCORD HEALTHCARE, INC.
$23
Epizyme, Inc.,
$23
Jazz Pharmaceuticals Inc.
$22
Servier Pharmaceuticals LLC
$22
PROGENICS PHARMACEUTICALS, INC.
$21
Spectrum Pharmaceuticals Inc.
$21
Mirati Therapeutics, Inc.
$20
G1 Therapeutics, Inc.
$20
BTG INTERNATIONAL, INC.
$16
Pharming Healthcare, Inc.
$16
Roche Diagnostics Corporation
$15
Lexicon Pharmaceuticals, Inc.
$14
TG THERAPEUTICS, INC.
$14
Alexion Pharmaceuticals, Inc.
$12
Merit Medical Systems Inc
$6
Top 3 companies account for 17.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRACAnalysis CDx · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CYRAMZA · Cabometyx · Cresemba · DARZALEX · DIS navify software · Doptelet · ELITEK · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · Folotyn · GAVRETO · GAZYVA · GILOTRIF · Gamifant · Gazyva · Halaven · IBRANCE · ILLUCCIX · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Idhifa · Imbruvica · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYCHOICE CDX · MYRISK · NERLYNX · NINLARO · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONCASPAR · ONIVYDE · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · OXLUMO · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PRECISETUMOR · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Pomalyst · Prolia · QINLOCK · REBLOZYL · RECOTHROM · ROLVEDON · RUCONEST · RYBREVANT · RYZNEUTA · Reblozyl · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SPY-PHI SYSTEM · StabiliT System · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TEVIMBRA · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Turalio · UKONIQ · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Vitrakvi · Vonjo · Voraxaze · WELIREG · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematologists within 10 mi
6
Per 100K population
1.1
County median income
$73,513
Nearest hospital
PROVIDENCE HOLY FAMILY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Andrei is a mixed practice specialist, with above-average Medicare volume (top 8% in WA), with low-engagement industry engagement in the top 19% of WA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Andrei experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Andrei performed 13,200 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Andrei receive payments from pharmaceutical companies?
Yes. Dr. Andrei received a total of $17,918 from 92 companies across 925 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Andrei's costs compare to other hematologists in Spokane?
Dr. Andrei's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Andrei) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Spokane
Browse hematologists in Spokane ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in WA
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in WA
Which WA hematologists receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology